Fidelity Investments’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Sell |
5,534,516
-54,358
| -1% | -$255K | ﹤0.01% | 1610 |
|
|
2025
Q1 | $20.4M | Sell |
5,588,874
-100,845
| -2% | -$368K | ﹤0.01% | 1671 |
|
|
2024
Q4 | $26.9M | Sell |
5,689,719
-644,265
| -10% | -$3.04M | ﹤0.01% | 1621 |
|
|
2024
Q3 | $59M | Sell |
6,333,984
-49,307
| -0.8% | -$459K | ﹤0.01% | 1307 |
|
|
2024
Q2 | $36.7M | Buy |
6,383,291
+3,692,155
| +137% | +$21.2M | ﹤0.01% | 1432 |
|
|
2024
Q1 | $18.1M | Sell |
2,691,136
-118,873
| -4% | -$798K | ﹤0.01% | 1693 |
|
|
2023
Q4 | $18.1M | Sell |
2,810,009
-88,210
| -3% | -$569K | ﹤0.01% | 1665 |
|
|
2023
Q3 | $14.5M | Sell |
2,898,219
-9,506
| -0.3% | -$47.5K | ﹤0.01% | 1708 |
|
|
2023
Q2 | $20.5M | Sell |
2,907,725
-107,287
| -4% | -$755K | ﹤0.01% | 1625 |
|
|
2023
Q1 | $18.7M | Sell |
3,015,012
-102,382
| -3% | -$635K | ﹤0.01% | 1632 |
|
|
2022
Q4 | $19.9M | Sell |
3,117,394
-298,938
| -9% | -$1.91M | ﹤0.01% | 1615 |
|
|
2022
Q3 | $29.3M | Sell |
3,416,332
-17,546
| -0.5% | -$151K | ﹤0.01% | 1470 |
|
|
2022
Q2 | $46.7M | Buy |
3,433,878
+238,012
| +7% | +$3.24M | ﹤0.01% | 1296 |
|
|
2022
Q1 | $48.7M | Buy |
3,195,866
+711,032
| +29% | +$10.8M | ﹤0.01% | 1398 |
|
|
2021
Q4 | $56.8M | Sell |
2,484,834
-35,300
| -1% | -$807K | ﹤0.01% | 1374 |
|
|
2021
Q3 | $35.1M | Sell |
2,520,134
-20,300
| -0.8% | -$283K | ﹤0.01% | 1571 |
|
|
2021
Q2 | $27.1M | Sell |
2,540,434
-32,600
| -1% | -$348K | ﹤0.01% | 1709 |
|
|
2021
Q1 | $33.2M | Sell |
2,573,034
-7,600
| -0.3% | -$98.1K | ﹤0.01% | 1572 |
|
|
2020
Q4 | $50.1M | Buy |
+2,580,634
| New | +$50.1M | ﹤0.01% | 1324 |
|